DUBOIS-STRINGFELLOW NATHALIE (SVP-CHIEF DEVELOPMENT OFFICER) received a stock award from SANGAMO THERAPEUTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2025ACC: 0001415889-25-005707
Officer· SVP-CHIEF DEVELOPMENT OFFICER
Since Feb 2026
+676.70K
Net shares
Net buyer
$3.2K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
680K acquired · 3.31K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.79K
Price / share
$1.00
Trade value
$1.79K
% of position
0.3%
2/24/2025
716.71K→714.92K
Common Stock
Direct
Shares
−1.51K
Price / share
$0.96
Trade value
$1.45K
% of position
0.2%
2/25/2025
714.92K→713.40K
Common Stock
Direct
Shares
+120K
Price / share
—
Trade value
—
% of position
16.8%
2/25/2025
713.40K→833.40K
Total
Net shares
+116.69K
Net value
-$3.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | F · Tax Withholding | −1.79K | $1.00 | $1.79K | 0.3% | 716.71K | 714.92K |
| Common Stock Direct | 2/25/2025 | F · Tax Withholding | −1.51K | $0.96 | $1.45K | 0.2% | 714.92K | 713.40K |
| Common Stock Direct | 2/25/2025 | A · Award | +120K | — | — | 16.8% | 713.40K | 833.40K |
| Total | +116.69K | -$3.24K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
560K shares
Shares
+560K
Strike price
0.9561
Held after
560K
Exercisable
—
2/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock560K shares | 2/25/2025 | A · Award | +560K | 0.9561 | — | 560K |